Form 8-K - Current report:
SEC Accession No. 0001104659-25-002822
Filing Date
2025-01-13
Accepted
2025-01-13 06:34:41
Documents
15
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253052d1_8k.htm   iXBRL 8-K 28144
2 EXHIBIT 99.1 tm253052d1_ex99-1.htm EX-99.1 27478
6 GRAPHIC tm253052d1_ex99-1img001.jpg GRAPHIC 3128
  Complete submission text file 0001104659-25-002822.txt   240541

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA swtx-20250113.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20250113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20250113_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT tm253052d1_8k_htm.xml XML 3575
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 25524703
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)